Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
1,538.00
+18.15 (1.19%)
Mar 28, 2025, 3:30 PM IST
Glenmark Pharmaceuticals Revenue
Glenmark Pharmaceuticals had revenue of 33.88B INR in the quarter ending December 31, 2024, with 35.14% growth. This brings the company's revenue in the last twelve months to 139.61B, up 6.10% year-over-year. In the fiscal year ending March 31, 2024, Glenmark Pharmaceuticals had annual revenue of 126.45B with 8.49% growth.
Revenue (ttm)
139.61B
Revenue Growth
+6.10%
P/S Ratio
3.11
Revenue / Employee
9.31M
Employees
14,989
Market Cap
434.87B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 126.45B | 9.90B | 8.49% |
Mar 31, 2023 | 116.56B | -6.49B | -5.28% |
Mar 31, 2022 | 123.05B | 13.61B | 12.44% |
Mar 31, 2021 | 109.44B | 2.87B | 2.69% |
Mar 31, 2020 | 106.57B | 7.92B | 8.03% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 516.03B |
Divi's Laboratories | 90.78B |
Cipla | 267.20B |
Mankind Pharma | 116.41B |
Apollo Hospitals Enterprise | 211.46B |
Zydus Lifesciences | 222.47B |
Aurobindo Pharma | 309.22B |
Alkem Laboratories | 127.57B |
Glenmark Pharmaceuticals News
- 3 days ago - HSBC upgrades Glenmark to ‘Buy’, sees 22% upside in stock price on potential ISB 2001 out-licensing deal, margin expansion visibility - Business Upturn
- 10 days ago - Stocks to watch today: Ola Electric, Hero MotoCorp, Manappuram Finance, JSW Energy, Hindalco, Glenmark, TVS, Concor, TCS, Paradeep Phosphates and more [March 21, 2025] - Business Upturn
- 19 days ago - Glenmark Pharma launches Empagliflozin in India, expands cardiometabolic portfolio - Business Upturn
- 21 days ago - Glenmark Pharma share price in focus after US OTC launch of Polyethylene Glycol 3350 - Business Upturn
- 4 weeks ago - Stocks to watch today: AstraZeneca, Glenmark, Aurobindo Pharma, Mankind Pharma, Bayer Crop in pharma updates - Business Upturn
- 4 weeks ago - Pharma Stocks: Glenmark down 2.43%, Divi’s Lab slips 2.10%, Biocon drops 2.57%, Glaxo plunges 3.44%, Nifty down 1.22% - Business Upturn
- 5 weeks ago - Glenmark settles US lawsuit over Generic Zetia and Vytorin for $7 million - Business Upturn
- 6 weeks ago - Glenmark Pharma shares jump 4% as Q3 revenue jumps 35.1% YoY - Business Upturn